HAPVYO

Class [005]
Pharmaceutical preparations for the treatment of cardiovascular diseases and disorders; pharmaceutical preparations for the treatment of central nervous system, namely, brain, movement, ocular motility and spinal cord diseases; pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely, growth and thyroid disorders; pharmaceutical preparations for the treatment of gastrointestinal diseases and disorders; pharmaceutical preparations for the treatment of genetic diseases and disorders, namely, enzyme deficiency; pharmaceutical preparations for the treatment of immunological diseases and disorders, namely, immunologic deficiency syndromes; pharmaceutical preparations for the treatment of infectious diseases and disorders, namely, respiratory infections, eye infections; pharmaceutical preparations for the treatment of inflammatory diseases and disorders, namely, inflammatory bowel diseases, inflammatory connective tissue diseases; pharmaceutical preparations for the treatment of menopausal diseases and disorders; pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely, diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical preparations for the treatment of autoimmune diseases and disorders; pharmaceutical preparations for the treatment of musculoskeletal diseases and disorders, namely, connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the treatment of neurological diseases and disorders, namely, brain injury, spinal cord injury, seizure disorders, pharmaceutical preparations for the treatment of oncological diseases and disorders; pharmaceutical preparations for the treatment of ophthalmological diseases and disorders; pharmaceutical preparations for the treatment of peripheral nervous system diseases and disorders, namely, convulsions and seizures; pharmaceutical preparations for the treatment of psychiatric diseases and disorders, namely, anxiety, mood disorders, schizophrenia, cognitive and bipolar disorders, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical preparations for the treatment of renal, respiratory, urogenital, urological, osteopathic, hematological and pulmonary diseases and disorders and pharmaceutical preparations for the treatment of viral diseases and disorders, namely, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical preparations for the treatment pain and diabetes; pharmaceutical preparations for use in regenerative medicine, namely the use of platelet rich plasma stem cells and scaffolds for the treatment of injuries and degeneration of joints; pharmaceutical preparations, namely, antibacterial preparations, antifungal preparations, antiviral preparations, dermatological preparations, immunosuppressants, and tissue repair preparations; human vaccines